ID
31324
Beschreibung
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Stichworte
Versionen (1)
- 13.08.18 13.08.18 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
13. August 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574
Adverse Event Report
- StudyEvent: ODM
Beschreibung
Adverse event
Alias
- UMLS CUI-1
- C0877248
Beschreibung
Adverse event
Datentyp
text
Alias
- UMLS CUI [1]
- C0877248
Beschreibung
Adverse event; Date of onset
Datentyp
date
Alias
- UMLS CUI [1]
- C2985916
Beschreibung
Adverse event; start time
Datentyp
time
Alias
- UMLS CUI [1]
- C2697889
Beschreibung
Adverse event; maximum intensity
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0518690
Beschreibung
Adverse event; Relationship; study drug
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
Beschreibung
Adverse event; Relationship; study drug; action taken
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C2826626
Beschreibung
Adverse event; Relationship; study drug; corrective therapies
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C0087111
- UMLS CUI [1,5]
- C0719519
Beschreibung
Adverse event; Outcome
Datentyp
text
Alias
- UMLS CUI [1]
- C1705586
Beschreibung
Adverse event; seriousness criteria
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1710056
Beschreibung
Adverse event; seriousness; date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C0808070
Beschreibung
Adverse event; seriousness; time
Datentyp
time
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1301880
Beschreibung
Adverse event; seriousness criteria
Datentyp
text
Alias
- UMLS CUI [1]
- C1710056
Beschreibung
Adverse event; significan bleeding
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0019080
Ähnliche Modelle
Adverse Event Report
- StudyEvent: ODM
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2348585 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C2826626 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0719519 (UMLS CUI [1,5])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,2])